Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Historical Portfolio Holders from Q2 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM STK CL A
Shares, excl. options Q1 2024
107 M
Holdings value Q1 2024
$649 M
Value change Q1 2024
-$9.86 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
168
Number of buys Q1 2024
92
Number of sells Q1 2024
-52
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.002%
CUSIP
03168L105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 107 M $649 M -$9.86 M $6.06 168
2023 Q4 109 M $660 M +$52.2 M $6.07 147
2023 Q3 102 M $430 M +$19.7 M $4.22 140
2023 Q2 97.3 M $302 M +$4.22 M $3.10 120
2023 Q1 96.3 M $134 M -$8.23 M $1.39 138
2022 Q4 102 M $202 M +$4.43 M $1.99 151
2022 Q3 91.8 M $186 M -$771 K $2.02 138
2022 Q2 97.7 M $311 M -$2.01 M $3.18 137
2022 Q1 92.5 M $385 M -$3.15 M $4.17 150
2021 Q4 100 M $478 M -$1.21 M $4.79 144
2021 Q3 100 M $535 M +$2.64 M $5.34 149
2021 Q2 99.5 M $509 M -$13.6 M $5.12 152
2021 Q1 101 M $683 M +$22.7 M $6.73 153
2020 Q4 92 M $420 M -$4.9 M $4.57 124
2020 Q3 93.1 M $361 M +$3.09 M $3.88 127
2020 Q2 101 M $480 M +$13.7 M $4.76 126
2020 Q1 98.1 M $341 M -$17.3 M $3.48 112
2019 Q4 101 M $487 M -$9.24 M $4.82 112
2019 Q3 108 M $314 M +$26.3 M $2.90 107
2019 Q2 95.2 M $683 M -$98 M $7.17 113
2019 Q1 102 M $1.44 B -$98.6 M $14.17 145
2018 Q4 116 M $1.57 B +$90.6 M $13.53 153
2018 Q3 108 M $2.4 B +$287 M $22.19 161
2018 Q2 97.4 M $1.6 B +$1.6 B $16.41 158